What is Letoval and how does it work?
Letoval, containing letrozole, is a non-steroidal aromatase inhibitor primarily used in postmenopausal women. In this group, estrogen, which can stimulate certain breast cancer growth, is mainly produced in fatty tissues via the aromatase enzyme. Letoval inhibits this enzyme, significantly lowering estrogen levels, which can slow or stop the growth of hormone-sensitive breast cancer cells. This mechanism differs from SERMs like tamoxifen, which block estrogen receptors rather than preventing estrogen production.
Medical uses of Letoval
Letoval's main application is in breast cancer treatment for postmenopausal women:
Breast Cancer Treatment
- Adjuvant Therapy: Used after initial treatment for early-stage hormone-receptor-positive breast cancer to lower recurrence risk. Treatment can last for five or more years.
- Extended Adjuvant Therapy: May be used after five years of tamoxifen therapy to further reduce recurrence.
- Advanced or Metastatic Breast Cancer: A first-line treatment to slow or stop the progression of advanced disease.
- Neoadjuvant Therapy: Can be used before surgery to shrink tumors.
Infertility Treatment
Letrozole has an off-label use for treating anovulatory infertility in premenopausal women. By lowering estrogen temporarily, it increases FSH and LH, stimulating ovulation. This use may be restricted in some areas and requires medical supervision.
Key considerations and side effects
Letoval can cause side effects related to reduced estrogen levels.
Common side effects
- Hot flashes, night sweats
- Joint, muscle, and bone pain
- Fatigue and weakness
- Headaches and dizziness
- Increased sweating
- Nausea and gastrointestinal issues
- Swelling
Potentially serious side effects
- Osteoporosis: Reduced bone density increases fracture risk. Bone density monitoring may be needed.
- Cardiovascular Issues: Possible increased risk of high cholesterol and heart problems.
- Liver Problems: Patients with liver disease may need dose adjustments.
- Vision Problems: Rarely, vision changes may occur.
Letoval vs. Tamoxifen: A comparison
Feature | Letoval (Letrozole) | Tamoxifen |
---|---|---|
Drug Class | Aromatase Inhibitor | SERM |
Mechanism | Blocks estrogen production | Blocks estrogen receptors |
Target Population | Primarily postmenopausal women | Premenopausal and postmenopausal women |
Side Effects | Increased risk of osteoporosis, joint pain | Increased risk of uterine cancer, blood clots |
Administration | Oral tablet, once daily | Oral tablet, once daily |
Drug Interactions | Reduced efficacy with tamoxifen or estrogen | May have reduced efficacy with letrozole |
Dosage and Administration
Letoval is usually taken as an oral tablet once daily, with or without food, preferably at a consistent time. Tablets should be swallowed whole. Dosage and duration are determined by a healthcare provider.
Patient guidance
- Do not stop Letoval without consulting your doctor.
- Report all side effects.
- Monitor bone health and consider supplements if recommended.
- Watch for signs of heart problems.
- Maintain a healthy lifestyle.
Conclusion
Letoval, containing letrozole, is a key treatment for hormone-sensitive breast cancer in postmenopausal women by inhibiting estrogen production. It is also used off-label for certain infertility cases. While effective, it has potential side effects requiring careful medical management. Understanding its uses and risks is vital for optimal treatment and safety. For more details on letrozole, consult resources like MedlinePlus.